4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023129
Chief Financial Officer bought 3,200 shares at $4.71 ($15,072)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reed Joshua Chief Financial Officer | 2019-09-05 | Purchase | +3,200 | $4.71 | $15,072 | 35,774 | D |
| Open-market purchases · 3,200 sh · avg $4.71 · $15,072 | |||||||
Loading xslF345X03/doc4.xml…